132 related articles for article (PubMed ID: 7775639)
21. Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid.
Sugimoto M; Mita S; Tokunaga M; Yamaguchi K; Cho I; Matsumoto M; Mochizuki M; Araki S; Takatsuki K; Ando M
Eur Respir J; 1993 Jul; 6(7):938-43. PubMed ID: 8370441
[TBL] [Abstract][Full Text] [Related]
22. [Human T-lymphotropic virus type 1 uveitis in children].
Kihara K; Tsuruda M; Ono A; Ikeda E; Hikita N; Miyata N; Mochizuki M
Nippon Ganka Gakkai Zasshi; 1997 Jun; 101(6):538-43. PubMed ID: 9209144
[TBL] [Abstract][Full Text] [Related]
23. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
24. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
25. Clinical course of HTLV-I-associated uveitis.
Nakao K; Ohba N; Nakagawa M; Osame M
Jpn J Ophthalmol; 1999; 43(5):404-9. PubMed ID: 10580663
[TBL] [Abstract][Full Text] [Related]
26. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
27. Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis.
Terada Y; Miyata K; Shoji N; Mochizuki M
Ocul Immunol Inflamm; 2023 Sep; 31(7):1416-1424. PubMed ID: 36803501
[TBL] [Abstract][Full Text] [Related]
28. HTLV-1 uveitis and Graves' disease presenting with sudden onset of blurred vision.
Kamoi K; Uchimaru K; Tojo A; Watanabe T; Ohno-Matsui K
Lancet; 2022 Jan; 399(10319):60. PubMed ID: 34973718
[No Abstract] [Full Text] [Related]
29. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
Reinwein D; Benker G; Lazarus JH; Alexander WD
J Clin Endocrinol Metab; 1993 Jun; 76(6):1516-21. PubMed ID: 8501160
[TBL] [Abstract][Full Text] [Related]
30. HTLV-I seroprevalence in patients with undefined uveitis in central Japan.
Goto K; Saeki K; Kurita M; Iijima Y; Miyake A; Ohno S
Jpn J Ophthalmol; 1994; 38(2):175-7. PubMed ID: 7967209
[TBL] [Abstract][Full Text] [Related]
31. HTLV-I uveitis.
Mochizuki M; Ono A; Ikeda E; Hikita N; Watanabe T; Yamaguchi K; Sagawa K; Ito K
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S50-6. PubMed ID: 8797704
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory manifestations of HTLV-1 and their therapeutic options.
Martin F; Taylor GP; Jacobson S
Expert Rev Clin Immunol; 2014 Nov; 10(11):1531-46. PubMed ID: 25340428
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan.
Kase S; Namba K; Kitaichi N; Iwata D; Ohno S; Ishida S
Jpn J Ophthalmol; 2013 Jul; 57(4):379-84. PubMed ID: 23608951
[TBL] [Abstract][Full Text] [Related]
34. HTLV-1 uveitis (HU).
Watanabe T; Mochizuki M; Yamaguchi K
Leukemia; 1997 Apr; 11 Suppl 3():582-4. PubMed ID: 9209460
[TBL] [Abstract][Full Text] [Related]
35. Pattern-reversal visual evoked potentials in patients with human T-lymphotropic virus type 1 uveitis.
Yukawa E; Urano T; Nakahara M; Miyata K; Matsuura T; Taketani F; Hara Y; Mochizuki M
Curr Eye Res; 2006 Jan; 31(1):37-42. PubMed ID: 16421018
[TBL] [Abstract][Full Text] [Related]
36. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
38. A multicenter case-control study of HTLV-I associated uveitis. Study Group for HTLV-I Associated Ocular Diseases.
Ohba N; Nakao K; Isashiki Y; Osame M; Sonoda S; Yashiki S; Yamaguchi K; Tajima K
Jpn J Ophthalmol; 1994; 38(2):162-7. PubMed ID: 7967207
[TBL] [Abstract][Full Text] [Related]
39. Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13.
Komiya I; Yamada T; Sato A; Kouki T; Nishimori T; Takasu N
J Clin Endocrinol Metab; 2001 Aug; 86(8):3540-4. PubMed ID: 11502776
[TBL] [Abstract][Full Text] [Related]
40. HTLV-I associated uveitis and hyperthyroidism.
Nakao K; Ohba N; Otsuka S; Okubo A; Yanagita T; Hashimoto N; Arimura H
Jpn J Ophthalmol; 1994; 38(1):56-61. PubMed ID: 7933698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
